Dr. Caixing Sun 孙才兴
Chief Physician
Department of Neurosurgical Oncology, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of neural and soft tissue tumors, including microsurgery for anterior skull base meningiomas, intraspinal tumors, and chordomas via micro bone window approaches.
Dr. Sun is Chief Physician and Director of Neurosurgery at Zhejiang Cancer Hospital. Holding a master’s in neurosurgery from Zhejiang University School of Medicine and currently pursuing a doctoral degree, Dr. Sun began practicing in 1990 and completed advanced training in neurosurgery at the State University of New York in 2006. Research focuses on nervous system tumors, particularly anti-angiogenesis in gliomas, intraoperative catheter brachytherapy, and permanent radioactive seed implantation.
Name order: in Chinese the family name comes first (Sun Caixing). Papers usually list the name as Caixing Sun or Sun C.
Selected publications
37 papers on PubMed matched by name and affiliation; 12 as first or senior author since 2016. Most recent first- or senior-author papers:
- Aging Dis, 2025 (senior author): Progress in Disease-Modifying Therapies for Parkinson's Disease. PubMed 41082301
- Mol Neurobiol, 2025 (senior author): Long Non-coding RNA CRNDE Promotes the Development of Glioma by Inducing Polarization of M2-Type Macrophages. PubMed 40320505
- Clin Med Insights Oncol, 2024 (senior author): Expression of CREBBP and EP300 Associated With Tumor Volume in Patients With Grade-3 Glioma: A Retrospective Analysis. PubMed 39429683
- Medicine (Baltimore), 2022 (senior author): Hub gene target of glioblastoma: LOX, SERPINH1 and TGFBI. PubMed 36397358
- Oxid Med Cell Longev, 2022 (senior author): Apatinib Induces Ferroptosis of Glioma Cells through Modulation of the VEGFR2/Nrf2 Pathway. PubMed 35602105
- Int J Gen Med, 2021 (senior author): Prognosis of Oligodendroglioma Patients Stratified by Age: A SEER Population-Based Analysis. PubMed 34916834
- Aging (Albany NY), 2021 (senior author): Long non-coding RNA TP73-AS1 is a potential immune related prognostic biomarker for glioma. PubMed 33589576
- Cancer Manag Res, 2020 (senior author): Combined Diagnostic Significance of Preoperative Serum β2-Microglobulin and Routine Blood Test in Patients with High-grade Glioma and Solitary Brain Metastasis. PubMed 33235502
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion